Besides these routine laboratory parameters, previous evidence has indicated that the novel glucose-related blood biomarkers, including the stress hyperglycemia ratio (SHR), glucose to estimated average glucose ratio (GAGR), and recently described prognostic markers such as the glucose to albumin ratio (GAR) and glucose to potassium ratio (GPR), have been increasingly utilized for the prognosis of various conditions, including cardiovascular disease, cancer, metabolic syndrome, and acute ischemic stroke [20–22]. This evidence concerns the gene ALB and cardiovascular disorder.